| Trial ID: | L4845 |
| Source ID: | NCT00154414
|
| Associated Drug: |
Liraglutide
|
| Title: |
Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: liraglutide
|
| Outcome Measures: |
Primary: HbA1c, after 14 weeks treatment | Secondary: Glycaemic control parameters (fasting plasma glucose, post prandial plasma glucose) after 14-week treatment|Body weight after 14 weeks.|Safety and tolerability
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE2
|
| Enrollment: |
226
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
|
| Start Date: |
2005-01
|
| Completion Date: |
2006-05
|
| Results First Posted: |
|
| Last Update Posted: |
2017-01-25
|
| Locations: |
Novo Nordisk Investigational Site, Tokyo, 1000005, Japan
|
| URL: |
https://clinicaltrials.gov/show/NCT00154414
|
